Lifecare AS
OSE:LIFE

Watchlist Manager
Lifecare AS Logo
Lifecare AS
OSE:LIFE
Watchlist
Price: 0.4095 NOK -0.12% Market Closed
Market Cap: kr122.1m

Lifecare AS
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Lifecare AS
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Lifecare AS
OSE:LIFE
EPS (Diluted)
-kr2
CAGR 3-Years
-61%
CAGR 5-Years
-140%
CAGR 10-Years
N/A
Medistim ASA
OSE:MEDI
EPS (Diluted)
kr8
CAGR 3-Years
12%
CAGR 5-Years
18%
CAGR 10-Years
15%
O
Observe Medical ASA
OSE:OBSRV
EPS (Diluted)
kr0
CAGR 3-Years
58%
CAGR 5-Years
47%
CAGR 10-Years
N/A
No Stocks Found

Lifecare AS
Glance View

Market Cap
122.1m NOK
Industry
Health Care

Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

LIFE Intrinsic Value
0.2576 NOK
Overvaluation 37%
Intrinsic Value
Price kr0.4095

See Also

What is Lifecare AS's EPS (Diluted)?
EPS (Diluted)
-2.4 NOK

Based on the financial report for Dec 31, 2025, Lifecare AS's EPS (Diluted) amounts to -2.4 NOK.

What is Lifecare AS's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-140%

Over the last year, the EPS (Diluted) growth was -50%. The average annual EPS (Diluted) growth rates for Lifecare AS have been -61% over the past three years , -140% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett